Menu
GeneBe

KCNMB1

potassium calcium-activated channel subfamily M regulatory beta subunit 1, the group of Potassium calcium-activated channel subfamily M regulatory beta subunits

Basic information

Region (hg38): 5:170374670-170389634

Links

ENSG00000145936NCBI:3779OMIM:603951HGNC:6285Uniprot:Q16558AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KCNMB1 gene.

  • Inborn genetic diseases (13 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNMB1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
13
clinvar
13
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 13 0 1

Variants in KCNMB1

This is a list of pathogenic ClinVar variants found in the KCNMB1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-170378753-G-T not specified Uncertain significance (Apr 07, 2023)2534126
5-170378801-G-C not specified Uncertain significance (Jan 03, 2022)2269024
5-170378844-C-T not specified Uncertain significance (Sep 01, 2021)3113434
5-170378846-C-T not specified Uncertain significance (Apr 25, 2022)2217355
5-170378862-G-A KCNMB1-related disorder Benign (Jul 30, 2019)3049582
5-170378867-G-A not specified Uncertain significance (Nov 30, 2022)2225607
5-170378901-A-T not specified Uncertain significance (Nov 12, 2021)2377700
5-170378943-A-C not specified Uncertain significance (Dec 06, 2021)2211828
5-170378960-G-A not specified Uncertain significance (Oct 12, 2021)2354643
5-170383686-T-C not specified Uncertain significance (Feb 22, 2023)2469837
5-170383695-C-T not specified Uncertain significance (May 11, 2022)2206806
5-170383707-G-A not specified Uncertain significance (Apr 12, 2022)2224163
5-170383744-C-G not specified Uncertain significance (Sep 27, 2021)2372588
5-170383745-G-A KCNMB1-related disorder Likely benign (Jun 26, 2019)3043247
5-170383792-C-T Hypertension, diastolic, resistance to • KCNMB1-related disorder Benign (Nov 26, 2019)5941
5-170385354-A-G not specified Uncertain significance (Jun 06, 2023)2533850
5-170385394-G-A Benign (Dec 08, 2017)779246
5-170385435-G-T not specified Uncertain significance (Aug 22, 2023)2596722

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KCNMB1protein_codingprotein_codingENST00000274629 315007
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002070.2821256850631257480.000251
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2191121190.9440.000007341223
Missense in Polyphen5552.2031.0536502
Synonymous-0.03215655.71.010.00000382395
Loss of Function0.18899.630.9355.13e-793

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005030.000503
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00009240.0000924
European (Non-Finnish)0.0003430.000343
Middle Eastern0.0001630.000163
South Asian0.0001310.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. Increases the apparent Ca(2+)/voltage sensitivity of the KCNMA1 channel. It also modifies KCNMA1 channel kinetics and alters its pharmacological properties. It slows down the activation and the deactivation kinetics of the channel. Acts as a negative regulator of smooth muscle contraction by enhancing the calcium sensitivity to KCNMA1. Its presence is also a requirement for internal binding of the KCNMA1 channel opener dehydrosoyasaponin I (DHS-1) triterpene glycoside and for external binding of the agonist hormone 17-beta-estradiol (E2). Increases the binding activity of charybdotoxin (CTX) toxin to KCNMA1 peptide blocker by increasing the CTX association rate and decreasing the dissociation rate.;
Pathway
Vascular smooth muscle contraction - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Insulin secretion - Homo sapiens (human);Neuronal System;Hemostasis;Ca2+ activated K+ channels;cGMP effects;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;Potassium Channels (Consensus)

Recessive Scores

pRec
0.136

Intolerance Scores

loftool
0.731
rvis_EVS
0.35
rvis_percentile_EVS
74.37

Haploinsufficiency Scores

pHI
0.121
hipred
N
hipred_score
0.245
ghis
0.519

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.754

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Kcnmb1
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); renal/urinary system phenotype; muscle phenotype;

Gene ontology

Biological process
detection of calcium ion;potassium ion transport;chemical synaptic transmission;aging;cellular response to ethanol;cellular response to hypoxia;potassium ion transmembrane transport;positive regulation of blood vessel diameter;positive regulation of potassium ion transmembrane transport;cellular response to bile acid
Cellular component
plasma membrane;voltage-gated potassium channel complex
Molecular function
calcium-activated potassium channel activity;potassium channel regulator activity